California State Teachers Retirement System (CalSTRS)’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.4K Sell
1,540
-213
-12% -$2.44K ﹤0.01% 2454
2025
Q4
$18K Sell
1,753
-37
-2% -$312 ﹤0.01% 2564
2025
Q3
$10.4K Buy
1,790
+1
+0.1% +$6 ﹤0.01% 2822
2025
Q2
$12K Sell
1,789
-14,433
-89% -$116K ﹤0.01% 2677
2025
Q1
$147K Hold
16,222
﹤0.01% 2326
2024
Q4
$280K Sell
16,222
-130
-0.8% -$2.35K ﹤0.01% 2305
2024
Q3
$261K Sell
16,352
-576
-3% -$9.08K ﹤0.01% 2338
2024
Q2
$241K Buy
16,928
+4,297
+34% +$61.1K ﹤0.01% 2354
2024
Q1
$179K Sell
12,631
-1,579
-11% -$22.3K ﹤0.01% 2431
2023
Q4
$214K Sell
14,210
-797
-5% -$11.8K ﹤0.01% 2445
2023
Q3
$237K Sell
15,007
-2,294
-13% -$36.1K ﹤0.01% 2476
2023
Q2
$262K Buy
17,301
+7,670
+80% +$106K ﹤0.01% 2506
2023
Q1
$140K Buy
9,631
+117
+1% +$1.56K ﹤0.01% 2640
2022
Q4
$129K Buy
+9,514
New +$167K ﹤0.01% 2704
2022
Q2
Sell
-4,446
Closed -$42K 3300
2022
Q1
$42K Sell
4,446
-570
-11% -$6.11K ﹤0.01% 3070
2021
Q4
$86K Buy
+5,016
New +$122K ﹤0.01% 3052

Other funds holding TRDA

California State Teachers Retirement System (CalSTRS)'s TRDA Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Entrada Therapeutics (TRDA) stake by 12% in Q1 2026, selling an estimated $2.44K and leaving 1,540 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.

California State Teachers Retirement System (CalSTRS) first reported a position in TRDA in Q4 2021 and has held it in 16 quarters since. The position peaked at $280K in Q4 2024. 120 funds tracked by Wall St. Rank hold TRDA as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,540 shares of Entrada Therapeutics worth $19.4K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 213 Entrada Therapeutics shares in Q1 2026, an estimated $2.44K.
  • Entrada Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2454 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Entrada Therapeutics in Q4 2021 and has held it in 16 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Entrada Therapeutics position peaked at $280K in Q4 2024.
  • 120 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.